Trends and Challenges of the Modern Pathology Laboratory for Biopharmaceutical Research Excellence.

This article focuses on the evolution, current state, and future challenges of the Modern Pathology Laboratory (MPL) in biopharmaceutical research, emphasizing its role in advancing drug discovery through integration of molecular, spatial, and digital pathology technologies. It outlines how traditional anatomic pathology laboratories have transitioned into MPLs by incorporating high-plex spatial "-omics" assays, whole slide imaging, and computational analytics to generate multidimensional tissue data critical for target validation, biomarker development, and safety assessment. The article discusses key components such as tissue biobanking, assay development and validation, quality assurance, and the necessity of robust laboratory information management systems to handle complex data workflows. It also highlights the importance of interdisciplinary collaboration among pathologists, molecular scientists, bioinformaticians, and digital image analysts, as well as the pressing need for structured training and formal certification in molecular and computational pathology to equip professionals for the demands of modern biopharmaceutical research.